摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-((4-chlorophenyl)amino)phenol | 66282-78-8

中文名称
——
中文别名
——
英文名称
3-((4-chlorophenyl)amino)phenol
英文别名
3-(4-chloroanilino)phenol
3-((4-chlorophenyl)amino)phenol化学式
CAS
66282-78-8
化学式
C12H10ClNO
mdl
——
分子量
219.671
InChiKey
GSHBBDLSLCDLCP-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    111-112 °C
  • 沸点:
    364.7±22.0 °C(Predicted)
  • 密度:
    1.324±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.7
  • 重原子数:
    15
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    32.3
  • 氢给体数:
    2
  • 氢受体数:
    2

反应信息

  • 作为产物:
    描述:
    4-溴氯苯3-氨基苯酚 在 chloro[2-(dicyclohexylphosphino)-3,6-dimethoxy-2',4',6'-triisopropyl-1,1'-biphenyl][2-(2-aminoethyl)phenyl]palladium(ll) 、 sodium t-butanolate 作用下, 以 1,4-二氧六环 为溶剂, 反应 1.0h, 以93%的产率得到3-((4-chlorophenyl)amino)phenol
    参考文献:
    名称:
    Orthogonal Cu- and Pd-Based Catalyst Systems for the O- and N-Arylation of Aminophenols
    摘要:
    O- or N-arylated aminophenol products constitute a common structural motif in various potentially useful therapeutic agents and/or drug candidates. We have developed a complementary set of Cu- and Pd-based catalyst systems for the selective O- and N-arylation of unprotected aminophenols using aryl halides. Selective O-arylation of 3- and 4-aminophenols is achieved with copper-catalyzed methods employing picolinic acid or CyDMEDA, trans-N,N'-dimethyl-1,2-cyclohexanediamine, respectively, as the ligand. The selective formation of N-arylated products of 3- and 4-aminophenols can be obtained with BrettPhos precatalyst, a biarylmonophosphine-based palladium catalyst. 2-Aminophenol can be selectively N-arylated with CuI, although no system for the selective O-arylation could be found. Coupling partners with diverse electronic properties and a variety of functional groups can be selectively transformed under these conditions.
    DOI:
    10.1021/ja9081815
点击查看最新优质反应信息

文献信息

  • Highly Chemoselective Iridium Photoredox and Nickel Catalysis for the Cross-Coupling of Primary Aryl Amines with Aryl Halides
    作者:Martins S. Oderinde、Natalie H. Jones、Antoine Juneau、Mathieu Frenette、Brian Aquila、Sharon Tentarelli、Daniel W. Robbins、Jeffrey W. Johannes
    DOI:10.1002/anie.201604429
    日期:2016.10.10
    visible‐light‐promoted iridium photoredox and nickel dual‐catalyzed crosscoupling procedure for the formation C−N bonds has been developed. With this method, various aryl amines were chemoselectively cross‐coupled with electronically and sterically diverse aryl iodides and bromides to forge the corresponding C−N bonds, which are of high interest to the pharmaceutical industries. Aryl iodides were found to be a more
    已经开发了可见光促进的光氧化还原和双催化交叉偶联过程,以形成CN键。通过这种方法,将各种芳基胺与电子和空间上不同的芳基化物和化物进行化学选择性交联,以形成相应的C-N键,这在制药工业中引起了极大的兴趣。发现芳基化物是更有效的亲电子偶联伴侣。偶联反应是在室温下进行的,没有严格排除分子氧,因此使这种新开发的Ir-photoredox / Ni双催化过程非常温和且操作简单。
  • Novel alpha adrenergic agents
    申请人:——
    公开号:US20030092741A1
    公开(公告)日:2003-05-15
    Aspects of the present invention are directed towards compounds of Formula I for the treatment of human erectile disorders including erectile dysfunction in men. 1 wherein: R 1 is hydrogen, halo, hydroxy, nitro, cyano, phenyl, trifluoromethyl, C 1 -C 6 alkyl, C 1 -C 6 alkoxy, carboxy, amino, cyclohexyl, C 1 -C 6 alkylamino, or (C 1 -C 6 alkyl) 2 amino; R 2 is hydrogen, halo, hydroxy, nitro, cyano, trifluoromethyl, C 1 -C 6 alkyl, C 1 -C 6 alkoxy, carboxy, amino, C 1 -C 6 alkylamino, or (C 1 -C 6 alkyl) 2 amino; R 3 is a group of the formula 2 R 4 is hydrogen or C 1 -C 6 alkyl; R 5 is hydrogen, halo, hydroxy, nitro, cyano, phenyl, trifluoromethyl, C 1 -C 6 alkyl, C 1 -C 6 alkoxy, carboxy, amino, C 1 -C 6 alkylamino, or (C 1 -C 6 alkyl) 2 amino; and R 6 is hydrogen, halo, hydroxy, nitro, cyano, trifluoromethyl, C 1 -C 6 alkyl, C 1 -C 6 alkoxy, carboxy, amino, C 1 -C 6 alkylamino, or (C 1 -C 6 alkyl) 2 amino; or pharmaceutically acceptable salts thereof
    本发明涉及一种用于治疗人类勃起障碍的化合物的公式I,包括男性勃起功能障碍。其中:R1为氢、卤素、羟基、硝基、基、苯基、三甲基、C1-C6烷基、C1-C6烷氧基、羧基、基、环己基、C1-C6烷基基或(C1-C6烷基)2基;R2为氢、卤素、羟基、硝基、基、三甲基、C1-C6烷基、C1-C6烷氧基、羧基、基、C1-C6烷基基或(C1-C6烷基)2基;R3为式2的基团;R4为氢或C1-C6烷基;R5为氢、卤素、羟基、硝基、基、苯基、三甲基、C1-C6烷基、C1-C6烷氧基、羧基、基、C1-C6烷基基或(C1-C6烷基)2基;R6为氢、卤素、羟基、硝基、基、三甲基、C1-C6烷基、C1-C6烷氧基、羧基、基、C1-C6烷基基或(C1-C6烷基)2基;或其药用盐。
  • Chemoselective Chan-Lam and reductive nitroarene coupling of boronic acid using an octahedral Ni-DMAP complex as catalyst
    作者:Hrishikesh Talukdar、Daisy Gogoi、Prodeep Phukan
    DOI:10.1016/j.tet.2023.133251
    日期:2023.2
    cross coupling and reductive nitroarene coupling using boronic acid as coupling partner. Reaction of amines, thiols, azides, and tosyl azides with boronic acids could be achieved in presence of 10 mol % of the catalyst in methanol at 80 °C without using extra base. The current protocol is highly selective for primary amines in presence of secondary amines, thiols and phenols. Reductive coupling of a
    开发了一种八面体 Ni-DMAP 配合物作为C- N 和C- S 交叉偶联和使用硼酸作为偶联剂的还原性硝基芳烃偶联的催化剂。胺、醇、叠氮化物甲苯磺酰叠氮化物硼酸的反应可以在 10 mol% 的催化剂存在下于 80 °C 的甲醇中实现,无需使用额外的碱。目前的协议在仲胺、醇和存在下对伯胺具有高度选择性。使用相同的催化剂也成功地实现了一系列硝基芳烃硼酸的还原偶联。
  • Copper Mediated Formation of Carbon-Heteroatom Bonds Using Organoboron Reagents and Ultrasound
    作者:George W. Kabalka、Bryan J. Musolino
    DOI:10.3987/com-14-s(k)18
    日期:——
    This report summarizes research efforts focused on copper acetate mediated reactions to form new carbon-heteroatom bonds using organoboron reagents under ultrasound irradiation. The method involves the application of ultrasound irradiation to the Chan-Evans-Lam reaction to achieve O-arylation of phenols, N-arylation of anilines and indoles, and S-arylation of thiols. Ultrasound irradiation was found to decrease reaction times from 72 hours to 4 hours while improving the product yields an average of 20%(1) Representative C-O, C-N, and C-S coupling reactions were successfully scaled-up from the milligram to gram levels while maintaining good product yields offering potential applications in industrial processes.
  • DE515208
    申请人:——
    公开号:——
    公开(公告)日:——
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫